1. Home
  2. AKR vs DNLI Comparison

AKR vs DNLI Comparison

Compare AKR & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acadia Realty Trust

AKR

Acadia Realty Trust

HOLD

Current Price

$20.76

Market Cap

2.6B

Sector

Real Estate

ML Signal

HOLD

Logo Denali Therapeutics Inc.

DNLI

Denali Therapeutics Inc.

HOLD

Current Price

$21.66

Market Cap

3.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AKR
DNLI
Founded
1993
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
3.2B
IPO Year
1996
2017

Fundamental Metrics

Financial Performance
Metric
AKR
DNLI
Price
$20.76
$21.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
12
Target Price
$22.33
$30.80
AVG Volume (30 Days)
981.9K
1.6M
Earning Date
05-07-2026
01-01-0001
Dividend Yield
3.90%
N/A
EPS Growth
N/A
N/A
EPS
0.10
N/A
Revenue
$410,757,000.00
N/A
Revenue This Year
$7.71
N/A
Revenue Next Year
$3.51
$3,886.00
P/E Ratio
$205.30
N/A
Revenue Growth
14.20
N/A
52 Week Low
$16.98
$10.57
52 Week High
$23.46
$23.77

Technical Indicators

Market Signals
Indicator
AKR
DNLI
Relative Strength Index (RSI) 54.65 59.74
Support Level $19.45 $13.29
Resistance Level $21.21 $23.77
Average True Range (ATR) 0.51 1.18
MACD 0.02 0.11
Stochastic Oscillator 34.43 76.51

Price Performance

Historical Comparison
AKR
DNLI

About AKR Acadia Realty Trust

Acadia Realty Trust is a real estate investment trust that specializes in the operation, management, leasing, renovation, and acquisition of shopping centers and mixed-use properties with retail components. The company operates through three segments: Core Portfolio segment consists primarily of high-quality retail properties located primarily in high-barrier-to-entry, densely-populated metropolitan areas with a long-term investment horizon; Investment Management segment holds primarily retail real estate in which the company co-invests with high-quality institutional investors; and Structured Financing segment consists of earnings and expenses related to notes and mortgages receivable Fees earned by the company as the general partner or managing member through Investment Management.

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

Share on Social Networks: